DiaMedica said that Dr Waters is an experienced scientist and pharmaceutical industry executive with more than 24 years of active leadership and involvement in drug development.
Dr Waters’s primary industry focus has centered on new drug development programs and he has built and managed multifunctional scientific departments while demonstrating a successful record of investigational new drug and new drug application preparations and submissions to the FDA, according to DiaMedica.
Reggie Bowerman, president and CEO of DiaMedica, said: “Dr Waters will be a critical asset in providing exemplary scientific and strategic leadership in progressing DiaMedica’s technology. He brings the necessary experience required to successfully develop our innovative agents to their full potential.”